VALLEY COTTAGE, N.Y. , July 03, 2018 (GLOBE NEWSWIRE) -- According to a new report, the global cancer diagnostics market is anticipated to grow at 8.9% CAGR during the forecast period 2016-2026. The market was valued at over US$ 32 Bn in 2016, and it expected to surpass US$ 76 Bn in revenues by 2026.
Biopsy/Tissue Diagnostics Largest Segment by Test Type
By test type, the global cancer diagnostics market has been segmented into tumour biomarker tests, imaging, biopsy, liquid biopsy, immunohistochemistry, and in situ hybridisation. Among these, biopsy/tissue diagnostics is the largest segment by test type, accounting for 36% revenue share. In terms of revenues, the global market was valued at US$ 11.76 Bn in 2016.
Request a Sample Report with Table of Contents and Figures : https://www.futuremarketinsights.com/reports/...ep-gb-1090
By disease indication, Future Market Insights segments the global cancer diagnostics market into:
- Breast cancer
- Lung cancer
- Colorectal cancer
- Melanoma
- Blood cancer
- Prostate cancer
- Ovarian cancer
- Stomach cancer
- Liver cancer
- Others
Among these, use of diagnostics was highest in lung cancer, breast cancer, and colorectal cancer. These three segments collectively accounted for over 45% revenue share by disease indication. Future Market Insights estimates these three segments to remain dominant during the period 2016-2026.
Hospital Associated Labs Largest End-user
By end-user, key segments include cancer research institutes, diagnostic imaging centers, independent diagnostic laboratories, hospital associated labs, and ‘others’. Use of cancer diagnostics systems was highest in hospital associated labs and independent diagnostic laboratories. This segment accounted for nearly 43% revenue share of the market in 2016. Future Market Insights estimates it to remain the largest end-user throughout the forecast period.
Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you : https://www.futuremarketinsights.com/askus/rep-gb-1090
North America Largest Market
North America is the most lucrative market for cancer diagnostics. The North America cancer diagnostics market was valued at over US$ 12.29 Bn, and it is projected to increase at a CAGR of 9.8% through 2026. The U.S. remains the dominant region for cancer diagnostics in North America, accounting for over 83% share. Future Market Insights projects market share of the U.S. to reach 87.1% by 2026. As is the case globally, lung cancer is the largest segment by disease indication in North America as well. This segment accounted for US$ 2.43 Bn in 2016, and is projected to grow at 11.7% CAGR throughout the forecast period. According to Future Market Insights’ research, elderly population aged 65 and above is more susceptible to lung cancer due to changing tissue landscape. Diagnosis and confirmation of lung cancer remains one of the most vexing challenges for pathologists and clinicians.
UK and Germany are the two largest markets for cancer diagnostics in Western Europe. According to Future Market Insights, these two markets collectively account for nearly 40% revenue share of the market. As per Institut für Krebsepidemiologie e.V statistics, Western Europe shows highest incidence of breast cancer ranging from 83 to 101 cases per 100,000 women (age 25 to 80 years) in 2014. On account of this, demand for cancer diagnostics systems will continue to remain strong in Western Europe.
China continues to be the largest market for cancer diagnostics in Asia Pacific excluding Japan (APEJ). The country accounted for nearly 32% revenue share of the market, and Future Market Insights estimates it to reach 33% by 2026.
Preview Analysis Global Cancer Diagnostics Market Segmentation By Test Type – Tumour Biomarkers Tests, Imaging, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridisation; By End User – Hospital Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centres, Cancer Research Institutes, Others; By Indication – Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Blood Cancer, Prostate Cancer, Ovarian Cancer, Stomach Cancer, Liver Cancer, Others: https://www.futuremarketinsights.com/reports/...ics-market
More from FMI’s Healthcare, Pharmaceuticals and Medical devices Intelligence:
- Empty Capsule Market Segmentation By Product Type - Gelatin (Hard)-Based Capsules and Vegetarian-Based Capsules; By Raw Material; By Route Of Administration - Oral Administration and Inhalation Administration; By End User: https://www.futuremarketinsights.com/reports/...les-market
- Veterinary Vaccines Market Segmentation By Product - Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines; By Disease Application Type - Anaplasmosis, Canine Parvovirus, Foot and Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, PRRS and Others; By Animal Type - Companion Animals, Livestock Animals and Equine; By Distribution Channel - Veterinary Clinics, Veterinary Hospitals, and Others: https://www.futuremarketinsights.com/reports/...nes-market
- Automated Breast Ultrasound System (ABUS) Market Segmentation by End User – Hospitals and Diagnostic Imaging Laboratories; by Key Regions- North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan (APEJ), Japan, and Middle East & Africa: https://www.futuremarketinsights.com/reports/...tem-market
About Us
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Browse More Healthcare, Pharmaceuticals and Medical devices Market Insights
Contact Us
Mr. Sudip Saha Future Market Insights 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): + 44 (0) 20 7692 8790 Sales: sales@futuremarketinsights.com Press Office: Press@futuremrketinsights.com FMI Blog: http://www.fmiblog.com/ Website: www.futuremarketinsights.com
